Scancell Holdings plc (AIM:SCLP)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 85.00
-1.40 (-1.62%)
Nov 4, 2026, 4:35 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 103.04 million as of November 4, 2026. It is the 22,701st most valuable company in the world and the 498th biggest in the United Kingdom. Its market cap has increased by 0.80% in one year.
Market Cap
103.04M
Enterprise Value
114.80M
Revenue
n/a
Global Rank
Country Rank
#498 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 103.04M, an increase of 3,187.75%. That is a compound annual growth rate of 22.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 103.04M | 0.29% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 304.51M |
| Avacta Group | 279.90M |
| Bioventix | 105.80M |
| 4basebio | 82.35M |
| Faron Pharmaceuticals Oy | 63.92M |
| Ondine Biomedical | 52.19M |
| Poolbeg Pharma | 49.17M |
| Hemogenyx Pharmaceuticals | 42.16M |